Global CGRP Antagonists Supply, Demand and Key Producers, 2023-2029

Global CGRP Antagonists Supply, Demand and Key Producers, 2023-2029

The global CGRP Antagonists market size is expected to reach $ 10000 million by 2029, rising at a market growth of 19.1% CAGR during the forecast period (2023-2029).

The CGRP (calprotectin gene-related peptide) antagonist market is a rapidly growing field focused on developing drugs to treat migraine and other neuropathic pain symptoms. These drugs reduce or prevent migraine attacks by inhibiting the effects of CGRP, providing patients with more effective pain management options. Several CGRP antagonists are already approved and in use on the market, and more new drugs are in development. Growth in this market is driven by expanding patient demand and scientific research, providing hope and an opportunity to improve the quality of life for migraine sufferers.

CGRP (calcitonin gene-related peptide) is a protein released around the nervous system of the brain. CGRP is widely distributed in peripheral neurons and central neurons, and its role is to participate in the process of pain transmission in the nervous system.

This report studies the global CGRP Antagonists production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for CGRP Antagonists, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGRP Antagonists that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global CGRP Antagonists total production and demand, 2018-2029, (K Units)

Global CGRP Antagonists total production value, 2018-2029, (USD Million)

Global CGRP Antagonists production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global CGRP Antagonists consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: CGRP Antagonists domestic production, consumption, key domestic manufacturers and share

Global CGRP Antagonists production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global CGRP Antagonists production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global CGRP Antagonists production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global CGRP Antagonists market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PFIZER INC(Biohaven), ABBVIE INC, Amgen, Teva, Eli Lilly and Company, Lundbeck and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGRP Antagonists market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CGRP Antagonists Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CGRP Antagonists Market, Segmentation by Type
Monoclonal Antibodies
CGRP Receptor Inhibitor

Global CGRP Antagonists Market, Segmentation by Application
Hospital
Clinic
Other

Companies Profiled:
PFIZER INC(Biohaven)
ABBVIE INC
Amgen
Teva
Eli Lilly and Company
Lundbeck
Novartis

Key Questions Answered

1. How big is the global CGRP Antagonists market?

2. What is the demand of the global CGRP Antagonists market?

3. What is the year over year growth of the global CGRP Antagonists market?

4. What is the production and production value of the global CGRP Antagonists market?

5. Who are the key producers in the global CGRP Antagonists market?